Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
Abivax SA, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the […]
Charter Healthcare Names New CEO and COO
Charter Healthcare, the post-acute provider platform of Pharos Capital Group, LLC, announced today that it […]
Axogen Appoints Jens Schroeder Kemp as Chief Marketing Officer
Axogen, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, […]
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]
Life Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific Officer
Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, […]
Harbinger Health Appoints Vincent Lozada as Chief Financial Officer
Harbinger Health, a biotechnology company pioneering the detection of early cancer, announced today the appointment […]
Adiso Therapeutics Announces the Appointment of Srikar Guntaka, M.D., as Medical Director
Adiso Therapeutics, a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and […]
Toragen Announces Appointment of Chief Scientific Officer
Toragen, a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs […]
Avita Care Solutions Names Dr. Christopher Hall First Chief Medical Officer
Avita Care Solutions, a national healthcare services organization committed to providing comprehensive, compassionate, and inclusive […]
Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer
Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more